In 1901 Alois Alzheimer
examined a 51 year woman with symptoms like behavioral disturbances and short-term memory loss, changing into dementia during the following years, until the patient's death in 1906.
Alzheimer's disease is a brain disorder named after German physician Alois Alzheimer
, who first described it in 1906.
The researcher added that the development was one of the most significant in the treatment of the disease since it was discovered in 1907 by Alois Alzheimer
in 1906 looked during autopsy procedures at brains of patients who died after suffering a specific type of mental confusion and deterioration, he found unusual clumps and fibers of proteins.
Since Alzheimer disease (AD) was first discovered by German psychiatrist and neuropathologist Alois Alzheimer
in 1906, the exploration for the medical treatments of this disease has been continuously going on for over a century (Green et al.
German neuropathologist Alois Alzheimer
and colleague Emil Kraepelin first described the plaques and tangles of Alzheimer's disease, following an autopsy of a woman with dementia at the start of the 20th century.
In 1906 the German neuropathologist Alois Alzheimer
microscopically identified the two specific markers characterizing the disease that now bears his name: sticky, abnormal clumps (amyloid plaques) that form within the empty space between brain cells with tangled bundles of fibres (tau neurofibrillary tangles) that erupt from within the clumps.
Dalessandro, BS, NHA, developed and manage the Alois Alzheimer
center in Cincinnati, which opened i in 1987 as the first freestanding dementia facility in the United States.
Although the German neuropathologist Alois Alzheimer
first reported the disease that would take his name in 1906, describing the ailment's distinctive amyloid plaques and neurofibrillary tangles in the preserved brain of housewife Auguste Deter, and Emil Kraepelin included the condition in his Textbook of Psychiatry in 1910, senile dementia was widely regarded as a normal variant of the aging process into the early 1980s.
If the dye, called florbetapir, wins regulatory approval, doctors will have the first tool for a quick, definitive diagnosis since German physician Alois Alzheimer
described the disease in 1906.
It is named after German neurologist Alois Alzheimer
, who first described it as a physical disease affecting the brain, which leads to the death of brain cells.
ALZHEIMER'S is so named because it was first described by the German neurologist Alois Alzheimer